Medifast Inc
NYSE:MED

Watchlist Manager
Medifast Inc Logo
Medifast Inc
NYSE:MED
Watchlist
Price: 22.87 USD -6.77%
Updated: May 23, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

302.8m
-2%
Assets
Growth Rates:
1 Year
-6%
3 Years
-7%
5 Years
+44%
7 Years
+146%
10 Years
+117%
91.8m
-15%
Liabilities
Growth Rates:
1 Year
-39%
3 Years
-39%
5 Years
+4%
7 Years
+286%
10 Years
+169%
211m
+5%
Equity
Growth Rates:
1 Year
+23%
3 Years
+21%
5 Years
+73%
7 Years
+113%
10 Years
+101%

Balance Sheet Decomposition
Medifast Inc

302.8m
Assets
91.8m
Liabilities
302.8m
Assets
91.8m
Liabilities
Current Assets 219.6m
Cash & Short-Term Investments 156.4m
Receivables 5.5m
Other Current Assets 57.7m
Non-Current Assets 83.2m
PP&E 65.5m
Other Non-Current Assets 17.7m
Current Liabilities 77.2m
Accounts Payable 71.2m
Accrued Liabilities 6m
Non-Current Liabilities 14.6m
Other Non-Current Liabilities 14.6m

Balance Sheet
Medifast Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
25
42
52
75
81
77
164
104
88
94
Cash Equivalents
25
42
52
75
81
77
164
104
88
94
Short-Term Investments
28
25
24
24
20
16
11
5
0
56
Total Receivables
7
3
3
3
1
7
1
1
0
9
Accounts Receivables
2
2
1
1
1
1
1
0
0
0
Other Receivables
5
2
1
2
0
5
0
0
0
0
Inventory
16
13
18
19
39
49
53
180
119
55
Other Current Assets
7
3
4
4
5
6
6
16
16
11
Total Current Assets
82
87
101
125
146
154
234
307
223
224
PP&E Net
34
29
20
19
20
39
38
81
76
67
PP&E Gross
34
29
20
19
20
39
38
81
76
67
Accumulated Depreciation
40
47
36
34
35
23
27
33
40
47
Other Long-Term Assets
1
0
0
2
4
2
4
11
18
19
Total Assets
116
N/A
116
+0%
121
+4%
146
+20%
169
+16%
195
+15%
276
+42%
398
+44%
316
-21%
310
-2%
Liabilities
Accounts Payable
12
11
10
16
22
23
36
71
59
48
Accrued Liabilities
10
8
11
15
29
39
54
74
55
42
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
5
4
4
6
9
18
21
25
27
2
Total Current Liabilities
27
24
24
37
60
79
111
170
141
92
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Deferred Income Tax
6
4
1
0
0
0
0
0
0
0
Other Liabilities
3
0
0
0
0
10
8
26
20
16
Total Liabilities
35
N/A
28
-22%
25
-8%
37
+48%
60
+62%
90
+49%
119
+32%
196
+65%
161
-18%
108
-33%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
79
89
94
104
131
169
154
190
140
175
Additional Paid In Capital
1
0
3
5
9
0
8
12
22
27
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
Treasury Stock
0
0
0
0
31
64
5
0
6
0
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
81
N/A
89
+10%
96
+8%
109
+13%
109
+0%
105
-4%
157
+50%
203
+29%
155
-23%
201
+30%
Total Liabilities & Equity
116
N/A
116
+0%
121
+4%
146
+20%
169
+16%
195
+15%
276
+42%
398
+44%
316
-21%
310
-2%
Shares Outstanding
Common Shares Outstanding
12
12
12
12
12
12
12
12
11
11

See Also

Summary
MED intrinsic value, competitors valuation, and company profile.
DCF Valuation
MED stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MED stock valuation using valuation multiples.
Wall Street Estimates
MED price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MED stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 140,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.